Smoking Young Asthmatics: Change of Inflammation During Tobacco Cessation and Steroid Treatment

NCT02233231 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2020-02-05

No results posted yet for this study

Summary

This is a study describing changes in inflammation of the airways in asthmatics before and after smoking cessation and steroid treatment.

Conditions

Interventions

DRUG

Varenicline

Varenicline 2 mg x 1 day 7 to week 12

DRUG

Placebo

similar tabl

Sponsors & Collaborators

  • Vibeke Backer

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-05-31
Completion
2013-05-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02233231 on ClinicalTrials.gov